I-Chiun Precision Industry Co., Ltd. (TPE:2486)

G1 Therapeutics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,445	1,355	1,492	1,312	1,149	1,039
Short-Term Investments	86.33	85.24	79.83	79.85	-	-
Trading Asset Securities	39.34	136.59	137.4	124.68	5.52	5.85
Cash & Short-Term Investments	1,571	1,576	1,710	1,517	1,154	1,044
Cash Growth	-26.43%	-7.79%	12.72%	31.41%	10.53%	11.85%
Accounts Receivable	2,396	2,467	2,133	1,900	2,459	1,527
Other Receivables	64.81	90.05	94.09	38.96	51.66	58.28
Receivables	2,461	2,557	2,227	1,939	2,511	1,585
Inventory	1,293	1,378	1,152	1,327	1,549	747.35
Other Current Assets	153.67	144.78	148.97	61.69	144.98	122.01
Total Current Assets	5,478	5,656	5,237	4,845	5,359	3,499
Property, Plant & Equipment	5,536	4,652	2,120	2,405	2,491	2,106
Long-Term Investments	61.87	71.72	20	-	-	-
Other Intangible Assets	21.82	23.21	24.35	19.95	14.51	8.36
Long-Term Deferred Tax Assets	77.2	73.27	112.98	116.38	163.06	152.43
Other Long-Term Assets	451.61	539.59	282.59	407.25	459.81	307.67
Total Assets	11,626	11,015	7,797	7,793	8,488	6,074
Accounts Payable	703.87	715.26	642.62	480.77	756.27	576.71
Accrued Expenses	224	259.79	180.17	136.49	230.25	99.32
Short-Term Debt	691	734.34	646.31	697.99	811.29	384.15
Current Portion of Long-Term Debt	18.72	15.62	966.67	261.67	25	593.2
Current Portion of Leases	19.35	21.69	58.87	52.75	52.13	36.57
Current Income Taxes Payable	11.04	2.97	10.14	11.43	7.58	-
Current Unearned Revenue	18.29	14.24	0.24	14.94	31.32	35.31
Other Current Liabilities	317.3	241.29	183.27	192.93	284.86	157.59
Total Current Liabilities	2,004	2,005	2,688	1,849	2,199	1,883
Long-Term Debt	3,864	3,186	6.67	977.08	1,220	873.8
Long-Term Leases	3.19	7.37	294.48	340.04	392.1	40.49
Long-Term Deferred Tax Liabilities	345.16	330.83	321.42	299.66	308.24	244.99
Other Long-Term Liabilities	66.29	9.27	55.13	58.02	66.29	67.46
Total Liabilities	6,316	5,630	3,414	3,573	4,239	3,171
Common Stock	2,340	2,340	2,220	2,220	2,220	2,020
Additional Paid-In Capital	2,711	2,776	1,864	1,814	1,848	1,157
Retained Earnings	200.34	237.42	359.29	249.28	222.67	-154.04
Treasury Stock	-	-	-39.54	-60.7	-	-
Comprehensive Income & Other	-102.54	-144.67	-212.68	-179.51	-217.75	-177.02
Total Common Equity	5,149	5,208	4,191	4,043	4,072	2,845
Minority Interest	161.79	177.32	192.12	177.72	177.08	57.46
Shareholders' Equity	5,310	5,386	4,383	4,221	4,249	2,903
Total Liabilities & Equity	11,626	11,015	7,797	7,793	8,488	6,074
Total Debt	4,597	3,965	1,973	2,330	2,501	1,928
Net Cash (Debt)	-3,026	-2,389	-263.29	-812.7	-1,346	-883.83
Net Cash Per Share	-13.08	-10.48	-1.20	-3.65	-6.41	-4.47
Filing Date Shares Outstanding	233.96	233.96	220.2	219.26	221.96	201.96
Total Common Shares Outstanding	233.96	233.96	220.2	219.26	221.96	201.96
Working Capital	3,475	3,651	2,549	2,996	3,161	1,616
Book Value Per Share	22.01	22.26	19.03	18.44	18.35	14.09
Tangible Book Value	5,127	5,185	4,167	4,023	4,058	2,837
Tangible Book Value Per Share	21.91	22.16	18.92	18.35	18.28	14.05
Land	2,987	2,132	113.76	113.76	113.76	113.76
Buildings	1,929	1,893	915.94	926.84	919.84	913.36
Machinery	2,331	2,287	2,162	2,433	2,332	2,625

Source: S&P Global Market Intelligence. Standard template. Financial Sources.